Article Text

other Versions

PDF
Original article
Progressive rise in red cell distribution width is associated with poor outcome after transcatheter aortic valve implantation
  1. Nay Aung1,
  2. Rafal Dworakowski1,
  3. Jonathan Byrne1,
  4. Emma Alcock1,
  5. Ranjit Deshpande1,
  6. Kailasam Rajagopal1,
  7. Beth Brickham1,
  8. Mark J Monaghan1,
  9. Darlington O Okonko2,
  10. Olaf Wendler1,
  11. Philip A MacCarthy1
  1. 1Cardiovascular Division, King's College Hospital and King's Health Partners, London, UK
  2. 2Department of Cardiology, University College London Hospital, London, UK
  1. Correspondence to Dr Philip MacCarthy, Cardiovascular Department, King's College Hospital, Denmark Hill, London SE5 9RS, UK; philip.maccarthy{at}nhs.net

Abstract

Objective To investigate the prognostic value of baseline and temporal changes in red cell distribution width (RDW) in patients undergoing transcatheter aortic valve implantation (TAVI).

Design Single-centre retrospective observational study.

Setting Tertiary cardiac centre.

Patients 175 patients undergoing TAVI were included in this study.

Main outcome measure Survival.

Results We analysed data from 175 TAVI patients (mean (±SD) age 83±7 years, 49% men, mean Logistic EuroSCORE 23±1, 66% preserved left ventricular ejection fraction (LVEF)). Immediately pre-TAVI, mean RDW was 14.6±1.6% with an RDW>15% in 29% of patients. Over median follow-up of 12 months, the median rate of change in RDW was 0.2% per month, and 51 (29%) patients died. On multivariate survival analyses, baseline RDW≥15.5% predicted death (adjusted HR 2.70, 95% CI 1.40 to 5.22, p=0.003) independently of LVEF, transfemoral approach, baseline pulmonary artery systolic pressure, moderate/severe mitral regurgitation and body mass index. A greater rate of increase in RDW over time was associated with increased mortality (adjusted HR 1.11, 95% CI 1.04 to 1.18, p=0.001) independently of baseline RDW and other significant temporal variables including a change in creatinine, bilirubin, mean cell haemoglobin concentration or urea. An increase in RDW>0.1%/month was associated with a twofold increased risk of mortality.

Conclusions Baseline RDW≥15.5% and a rising RDW over time strongly correlate to an increased risk of death post-TAVI, and could be used to refine risk stratification. Investigating and ameliorating the causes of RDW expansion may improve survival.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.